Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ehrsson

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Clinical Pharmacology|January 1, 1983
Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031)H Ehrsson, I Wallin, S O Nilsson, et al.
The European Journal of Neuroscience|September 13, 2001
Human brain activity in the control of fine static precision grip forces: an fMRI studyJ P Kuhtz-Buschbeck, H H Ehrsson, H Forssberg
Journal of Pharmaceutical Sciences|September 1, 1980
Degradation of chlorambucil in aqueous solutionH Ehrsson, S Eksborg, I Wallin, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1991
Efficacy of peptide bound m-L-sarcolysin (peptichemio) on melphalan resistant human myeloma cells in vitroR Lewensohn, J O Fernberg, H Ehrsson, et al.
Photo-Dermatology|June 1, 1988
Concentration of trimethylpsoralen in blood and skin after oral administrationA M Ros, G Wennersten, I Wallin, et al.
Scientific Reports|December 19, 2015
Owning the body in the mirror: The effect of visual perspective and mirror view on the full-body illusionCatherine Preston, Benjamin J Kuper-Smith, Henrik H Ehrsson
European Journal of Cancer & Clinical Oncology|May 1, 1989
Pharmacokinetics of oral melphalan in relation to renal function in multiple myeloma patientsA Osterborg, H Ehrsson, S Eksborg, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Inter- and intraindividual differences in oral chlorambucil pharmacokineticsP Hartvig, B Simonsson, G Oberg, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Oral melphalan pharmacokinetics--relation to dose in patients with multiple myelomaH Ehrsson, S Eksborg, A Osterborg, et al.
European Journal of Clinical Pharmacology|June 20, 2008
Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusionH Mahteme, I Wallin, B Glimelius, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Clinical Pharmacology|January 1, 1983
Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031)H Ehrsson, I Wallin, S O Nilsson, et al.
The European Journal of Neuroscience|September 13, 2001
Human brain activity in the control of fine static precision grip forces: an fMRI studyJ P Kuhtz-Buschbeck, H H Ehrsson, H Forssberg
Journal of Pharmaceutical Sciences|September 1, 1980
Degradation of chlorambucil in aqueous solutionH Ehrsson, S Eksborg, I Wallin, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1991
Efficacy of peptide bound m-L-sarcolysin (peptichemio) on melphalan resistant human myeloma cells in vitroR Lewensohn, J O Fernberg, H Ehrsson, et al.
Photo-Dermatology|June 1, 1988
Concentration of trimethylpsoralen in blood and skin after oral administrationA M Ros, G Wennersten, I Wallin, et al.
Scientific Reports|December 19, 2015
Owning the body in the mirror: The effect of visual perspective and mirror view on the full-body illusionCatherine Preston, Benjamin J Kuper-Smith, Henrik H Ehrsson
European Journal of Cancer & Clinical Oncology|May 1, 1989
Pharmacokinetics of oral melphalan in relation to renal function in multiple myeloma patientsA Osterborg, H Ehrsson, S Eksborg, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Inter- and intraindividual differences in oral chlorambucil pharmacokineticsP Hartvig, B Simonsson, G Oberg, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Oral melphalan pharmacokinetics--relation to dose in patients with multiple myelomaH Ehrsson, S Eksborg, A Osterborg, et al.
European Journal of Clinical Pharmacology|June 20, 2008
Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusionH Mahteme, I Wallin, B Glimelius, et al.
Pageof 11